Chronic Traumatic Encephalopathy (CTE) is a degenerative brain disease caused by repeated head impacts, and it looks different depending on when you catch it. What CTE looks like in the brain begins with abnormal tau protein tangles clustered around small blood vessels, followed by shrinking frontal and memory regions and shifts in behavior that families often notice before any scan confirms it.
Early warning signs can be as subtle as a short fuse and forgotten appointments, while later stages show visible atrophy on imaging.
The sections below walk through the brain changes, stage-by-stage symptoms, what scans can and cannot reveal, and realistic paths forward for athletes, veterans, and families navigating this disease.
Two Meanings of CTE and Why Context Matters
Before anything else, confirm which CTE you actually mean. The same three letters cover two completely different worlds, and mixing them up leads to wasted searches and confused conversations.
The Brain Disease
Chronic Traumatic Encephalopathy is a neurodegenerative condition, meaning brain cells progressively break down and die, tied to repeated head impacts. Most documented cases appear in contact-sport athletes and military veterans exposed to blast injuries, though abuse survivors with histories of repetitive head trauma also qualify. It is not the same as a single concussion; it accumulates over years of hits, many too mild to ring any alarm bell at the time.
The Educational Path
Career and Technical Education is a different world entirely: vocational programs preparing students for skilled trades and technical careers, from welding to cybersecurity. A job posting listing “CTE experience” or a high school brochure about CTE courses has nothing to do with the brain disease.
Whenever the context is sports, military service, head injuries, memory loss, or mood changes, assume the medical meaning. Whenever the context is high school coursework, trade schools, or career pathways, assume the educational meaning.
The Brain Disease Behind the Headlines
The medical version has been hiding in plain sight for nearly a century. It was first described in 1928 in boxers, originally called dementia pugilistica, the phrase “punch-drunk” capturing the slurred speech and stumbling gait doctors saw in aging fighters.
From Boxing Ring to Football Field
Recognition expanded slowly until the mid-2000s, when researchers at the Boston University CTE Center, including Ann McKee, began systematically examining donated brains from former athletes. Her team has since identified CTE in hundreds of former NFL players, transforming a once-dismissed complaint into a recognized medical diagnosis. The VA-BU-CLF Brain Bank, a joint effort between Boston University, the Concussion Legacy Foundation, and the U.S. Department of Veterans Affairs, has been central to that work.
Who Else Is at Risk
The same tau pathology has appeared in military veterans exposed to blast injuries and in survivors of repeated physical abuse. The common thread is cumulative subconcussive impacts, hits forceful enough to injure brain tissue but not severe enough to cause an obvious concussion, rather than any single dramatic blow.
Because those subconcussive impacts drive the damage, the next question is what they actually leave behind inside the skull.
What Happens Inside the Brain
The signature of CTE is microscopic, but the consequences are anything but.
Tau Protein and the Perivascular Pattern
Deep inside affected tissue, a protein called tau, which normally helps maintain the internal scaffolding of neurons, misfolds and clumps into tangles. In CTE these tau deposits cluster in a distinctive pattern around small blood vessels, a layout researchers call perivascular. That arrangement is unusual enough that a trained neuropathologist, a specialist who diagnoses brain diseases from tissue samples, can often distinguish CTE from other tau disorders at the microscope.
Which Regions Take the Hit
The damage concentrates in regions that govern personality, decision-making, and memory:
- Frontal cortex: judgment, impulse control, and planning
- Hippocampus: formation of new memories
- Amygdala: emotional regulation, fear, and aggression responses
- Brainstem and diencephalon (later stages): motor control, sleep, and basic autonomic regulation
Over time, these regions lose volume. The sulci (the grooves on the brain’s surface) widen, the ventricles (fluid-filled cavities deep inside) enlarge, and the cortical ribbon thins. In advanced cases the shrinkage is visible on routine imaging even before anyone considers the tau diagnosis.
What Brain Scans Can and Cannot Reveal
Imaging is useful, but it cannot deliver the answer most families are looking for.
The Limits of MRI and CT
Bleeding, large tumors, significant atrophy, or major trauma are the kinds of structural problems standard MRI and CT scans routinely catch. They cannot see tau tangles, which operate at a microscopic scale well below what these machines resolve. Early-stage disease frequently looks completely normal on a routine scan, which is one reason so many affected people go undiagnosed during life.
The Promise and Restriction of PET and Biomarkers
Specialized PET scans using tau-tracing radioligands, which are injectable molecules designed to bind to tau and light it up under the scanner, have identified CTE-like patterns in living former athletes, including the distinctive perivascular signal seen at autopsy. Blood and cerebrospinal fluid tests for tau and related proteins are advancing quickly, yet none is clinically validated for CTE specifically. The National Institute of Neurological Disorders and Stroke continues to fund that research.
| Scan Type | What It Can Show | What It Cannot Show |
|---|---|---|
| MRI | Atrophy, prior bleeds, structural lesions | Microscopic tau tangles |
| CT | Large bleeds, major atrophy, fractures | Microscopic tau tangles |
| Tau PET (research) | Patterns of tau buildup in some cases | Definitive diagnosis outside research |
| Blood / CSF biomarkers | Promising research signals | A clinically approved CTE test |
Until validated tools arrive, post-mortem neuropathological examination of brain tissue remains the only way to confirm CTE. Families who donate tissue to research banks help build the evidence base that future living-person tests will rely on.
Since living brains still can’t be screened for it, clinicians have had to rely on the symptom patterns that emerge instead.
Recognizing Symptoms Across the Four Stages
The clinical staging system most often referenced was developed at Boston University, building on earlier work by the Mayo Clinic and others. It sorts symptoms into four rough stages, with the understanding that real-life progression rarely follows a clean timeline.
Stage I: Subtle Warning Signs
Headaches pop up more often, attention drifts, and mood swings get sharper. A former athlete in his thirties might struggle to focus at work and snap at his kids for the first time. These changes are easy to attribute to stress, aging, or a bad sleep cycle.
Stage II: Mood and Memory Slip
Depression, impulsivity, irritability, and short-term memory lapses start interfering with daily life. The person forgets conversations, makes poor financial calls, or shows a flattened personality that family members quietly notice. Headaches often persist.
Stage III: Cognitive Decline Deepens
Executive dysfunction sets in, meaning the ability to plan, organize, and self-monitor breaks down. Aggression, paranoia, or erratic behavior can dominate. Cognitive decline becomes hard to hide, and work or relationships usually suffer.
Stage IV: Dementia and Motor Impairment
Severe memory loss, gait disturbance, slowed movement, and profound personality change require full-time care. The Aaron Hernandez case, in which the former NFL player was diagnosed with Stage III CTE after his death at 27, brought the youthful end of the spectrum into public view, though most cases surface later in life.
Symptoms overlap heavily with PTSD, depression, Alzheimer’s disease, and frontotemporal dementia, so any serious cognitive or behavioral change in someone with a history of head impacts deserves a full workup rather than a quick label.
Risk Factors, Diagnosis, and What Comes Next
There is no treatment that halts or reverses CTE. What exists is risk reduction, symptom management, and ongoing research that may eventually change the outlook.
Who Faces the Highest Risk
Risk climbs with the total number of head impacts, the force behind them, and the age at which exposure begins. Football players, boxers, hockey enforcers, rugby players, soccer headers, military service members exposed to blasts, and survivors of repeated abuse all show elevated rates. Genetic factors, including variants in genes like TMEM106B, appear to modify susceptibility in ways researchers are still mapping.
How Clinicians Approach a Living-Person Diagnosis
Doctors work with a probable diagnosis: documented exposure history, characteristic symptoms, and exclusion of better-explained causes. That process follows guidance from the Concussion in Sport Group Consensus Statement and the diagnostic framework published by NINDS. Management focuses on cognitive rehabilitation, psychiatric care, sleep treatment, exercise, and social support.
Prevention and the Path Forward
- Reduce subconcussive hits: limit contact practice, enforce proper tackling technique, and adjust rules in youth sports
- Upgrade protective equipment: helmets mitigate impact force but do not eliminate risk
- Track cumulative exposure: monitor headers in soccer, hits in practice, and blast exposure in military training
- Support biomarker research: validated tau PET and fluid tests would finally allow in-life diagnosis
- Encourage brain donation: research banks need tissue to refine staging and develop treatments
Final Thoughts
CTE is invisible on routine scans and confirmed only after death, yet it reshapes lives long before that final exam. The clearest signal you can act on is a pattern: years of head impacts followed by creeping changes in mood, memory, judgment, and movement. Spot the pattern early, document exposure history, and bring it to a specialist. Reducing subconcussive hits today remains the most effective way to prevent the disease tomorrow.
FAQ
What does CTE look like in the brain?
CTE looks like abnormal tau protein tangles clustered around small blood vessels in a perivascular pattern, along with shrinkage of the frontal cortex, hippocampus, and amygdala. As the disease progresses, sulci widen and ventricles enlarge, producing visible atrophy on imaging in advanced stages.
What are the early symptoms of CTE?
Headaches, mood swings, irritability, short-term memory lapses, and concentration problems often show up first. Because these overlap with stress, depression, and aging, the key signal is a pattern tied to a history of repeated head impacts rather than any single symptom.
What does CTE look like on a brain scan?
Standard MRI and CT scans usually show nothing abnormal in early CTE. In later stages, atrophy in the frontal and temporal lobes may appear, but only post-mortem neuropathological examination can confirm the diagnosis.
What causes CTE to develop?
CTE develops from cumulative repetitive head impacts, including subconcussive hits that never produce obvious symptoms. Contact-sport athletes, military veterans exposed to blasts, and abuse survivors face the highest documented risk.
How is CTE diagnosed?
During life, clinicians use exposure history, symptom evaluation, and research-grade tau PET or fluid biomarkers to suggest probable CTE. Definitive confirmation still requires post-mortem examination of brain tissue.
What are the four stages of CTE?
Subtle headaches and mood changes mark Stage I, giving way to memory lapses and depression in Stage II, then executive dysfunction and aggression in Stage III, and finally severe dementia with motor impairment in Stage IV.
